Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exparel vs Pain Pump for Pain Control After TSA
NCT04364867Phase 4Completed
- Sponsor
- Norton Healthcare
- Start
- Aug 2020
- Primary completion
- Feb 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of bupivacaine in postoperative pain (2 arms), sponsored by Norton Healthcare. Primary endpoint: Pain Score in the 24 Hours After Surgery. Started Aug 2020; status: completed.
02
Drugs
bupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT04364867.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04364867.